Five conversations every MedTech leader needs to hear before entering Asia

For years, the dominant MedTech narratives, from funding benchmarks to regulatory playbooks, were written in the US and Europe. Asia was often viewed as a market to enter later.

That is changing quickly. As healthcare demand grows and innovation accelerates across the region, Asia is becoming a priority market in its own right. This August, MedTech World Asia 2026 in Hong Kong will bring together founders, investors, operators, and policymakers to discuss the opportunities and challenges influencing the region’s future.

Here are five conversations already attracting attention.

1. East vs. West: Funding dynamics compared

Fundraising in Asia is not simply a smaller version of the US or European market. Investor expectations, deal structures, and due diligence processes vary significantly across regions.

This panel will explore how capital moves across Asian markets, what investors are looking for, and how founders can navigate these differences more effectively. For companies raising capital or investors looking to deploy it, understanding these dynamics is essential.

2. Scaling across borders: Winning market entry strategies in Asia-Pacific

There is no single Asian market. Every country has its own regulatory environment, reimbursement model, distribution network, and healthcare priorities.

This session focuses on the realities of expansion across the region. Panelists will discuss regulatory sequencing, market prioritisation, partnership strategies, and localisation. Attendees will gain practical insights into building a market entry strategy that reflects the diversity of Asia-Pacific.

3. Talent, manufacturing and supply chain: Building an Asia operations backbone

Growth requires more than funding. It requires strong operational foundations.

This panel brings together leaders who have built manufacturing operations, commercial teams, and regional supply chains across Asia. Discussion topics will include attracting local talent, managing cross-border operations, building supply chain resilience, and creating structures that support long-term growth.

For operators and executives, this is likely to be one of the most practical sessions of the event.

4. From pitch to scale: What makes MedTech startups win in Asia

Many startups secure funding. Far fewer successfully scale.

Investors, founders, and accelerator leaders will discuss what separates companies that grow from those that stall. Expect conversations around clinical validation, regulatory hurdles, market-entry challenges, and execution strategies.

For early-stage companies and investors, the session offers a realistic look at what success in Asia actually requires.

5. From Series A to IPO: Navigating the Asian capital stack

For ambitious MedTech companies, the goal extends beyond the next funding round.

This panel examines the full capital journey, from Series A through to public markets. Speakers will discuss milestones, investor expectations, growth metrics, and the narrative needed to attract later-stage capital. Founders will gain a clearer understanding of what investors look for and how to prepare for each stage of growth.

Why Hong Kong, why now?

Asia represents more than half of the world’s population and an increasing share of global healthcare spending. The region combines manufacturing strength, clinical expertise, regulatory innovation, and growing demand across multiple markets.

MedTech World Asia 2026 at the Hong Kong Convention and Exhibition Centre (HKCEC) provides a platform for the conversations that matter most, bringing together stakeholders from across the ecosystem for three days of discussion, networking, and collaboration.

The programme is still evolving, but these five panels already highlight the issues that will define the next chapter of MedTech in Asia.

Want to be part of MedTech World Asia 2026?

If you’re still looking to take the stage, the window is closing. There are still a few ways to participate before they’re gone:

• Speak – Share your expertise with a room full of the region’s most engaged MedTech leaders.
• Present – Bring your company, technology, or research to an audience that’s specifically here to discover what’s next.
• Partner – Align your organisation with the defining MedTech event in Asia this year.
• Active Investor? Apply for your Investor Pass and join the region’s capital conversation.